SauveBio to present at PEGS Boston 2026
SauveBio is pleased to announce that we will be presenting at and sponsoring the 22nd Annual PEGS Boston Summit, taking place May 11–15, 2026, at the Omni Boston Hotel at the Seaport in Boston, MA.
As an Innovation Showcase Sponsor, SauveBio’s Co-Founder, CEO & CSO, Hannah Sheehan, Ph.D., will deliver a 15-minute presentation in the Characterization of Novel Biotherapeutics track. Dr. Sheehan will discuss applications of advanced flow cytometry and organelle-level isolation in biotherapeutic research and development — capabilities that operate at a level of resolution not typically accessible through standard CRO workflows.
PEGS Boston is widely regarded as one of the premier annual gatherings for scientists and biopharma leaders working at the forefront of protein and antibody engineering, biotherapeutic development, and biologics characterization. We are proud to be part of the program.
If you or your team will be attending PEGS Boston, we would welcome the opportunity to connect. SauveBio will be available for one-on-one meetings throughout the conference week to discuss how our capabilities in cell sorting and flow cytometric analysis may support your program’s needs.
Event details
- Event: 22nd Annual PEGS Boston Summit
- Dates: May 11–15, 2026
- Location: Omni Boston Hotel at the Seaport, Boston, MA + Virtual
- Track: Characterization of Novel Biotherapeutics
- Sponsorship: Innovation Showcase Sponsor
- Website: PEGSummit.com
Schedule a meeting with our team
We will be scheduling one-on-one meetings throughout the conference week for teams interested in learning more about SauveBio’s services. To reserve time with us, please schedule a meeting or contact us directly.